bortezomib,lenalidomide,busulfan,dexamethasone
Takeda
#mmsm #ims2022 important negative study for bumel vs mel in mm asct, some signal in high risk patients subset. some increase toxicity. vod was reversible excellent efforts done in this trial with a long follow up 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities. No COI